Published in Vox Sang on November 21, 2011
Implementing mass-scale red cell genotyping at a blood center. Transfusion (2015) 1.60
The AQP1 mutation c.601delG causes the Co-negative phenotype in four patients belonging to the Romani (Gypsy) ethnic group. Blood Transfus (2013) 0.95
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014. Blood Transfus (2015) 0.77
Duffy blood group genotyping in Thai blood donors. Ann Lab Med (2015) 0.77
Distribution of DI*A and DI*B Allele Frequencies and Comparisons among Central Thai and Other Populations. PLoS One (2016) 0.75
Molecular typing for the Indian blood group associated 252G>C single nucleotide polymorphism in a selected cohort of Australian blood donors. Blood Transfus (2014) 0.75
Rare blood donors screening by multiplex PCR methods in Chinese Zhuang and Dong population and pedigree analysis. Int J Clin Exp Med (2015) 0.75
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
DNA commission of the International Society of Forensic Genetics: Recommendations on the interpretation of mixtures. Forensic Sci Int (2006) 3.20
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Forensic Sci Int (2006) 2.22
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Int J Legal Med (2006) 2.00
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Paternity Testing Commission of the International Society of Forensic Genetics. Recommendations on genetic investigations in paternity cases. Int J Legal Med (2003) 1.46
Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4. J Rheumatol (1980) 1.41
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
[The HL-A-system in paternity testing (author's transl)]. Z Rechtsmed (1974) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Defective macrophage function in a patient with common variable immunodeficiency. N Engl J Med (1982) 1.38
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
HLA antigens in inflammatory bowel disease. Gastroenterology (1982) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
DNA commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Int J Legal Med (2001) 1.28
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant (2005) 1.28
DNA Commission of the International Society for Forensic Genetics (ISFG): recommendations regarding the role of forensic genetics for disaster victim identification (DVI). Forensic Sci Int Genet (2006) 1.28
Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang (2003) 1.22
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
HLA-DR and Hashimoto's thyroiditis. Tissue Antigens (1980) 1.20
Nomenclature for factors of the HLA system, 1994. Tissue Antigens (1994) 1.19
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Nomenclature for factors of the HLA system, 1995. Hum Immunol (1995) 1.16
Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion (1996) 1.13
DNA commission of the International Society of Forensic Genetics: Recommendations on the evaluation of STR typing results that may include drop-out and/or drop-in using probabilistic methods. Forensic Sci Int Genet (2012) 1.11
Immunoglobulin allotype markers and HLA DR genes in type I diabetes mellitus. Metabolism (1984) 1.10
Strategy to detect chimerism in allogeneic bone marrow transplant recipients by PCR-amplification fragment length polymorphism analysis of microsatellite polymorphisms. Vox Sang (1995) 1.10
Nomenclature for factors of the HLA system, 1989. Tissue Antigens (1990) 1.10
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
Humoral immunodeficiency to bacterial antigens in patients with juvenile onset diabetes mellitus. Diabetologia (1976) 1.08
ISFG: recommendations regarding the use of non-human (animal) DNA in forensic genetic investigations. Forensic Sci Int Genet (2010) 1.06
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion (2001) 1.05
DNA Commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Forensic Sci Int (2001) 1.04
HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. J Rheumatol (1984) 1.02
Nomenclature for factors of the HLA system, 1990. Hum Immunol (1991) 1.01
Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) (1989) 1.00
Localization of MPI, PKM2, IDHM, and the alpha subunit of hexosaminidase (HEXA) to the q21 leads to qter region of human chromosome 15. Cytogenet Cell Genet (1978) 0.99
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol (1992) 0.98
Current status of solvent/detergent-treated frozen plasma, whole-blood inline filtration, and Creutzfeldt-Jakob disease. Transfusion (1999) 0.97
An update to HLA nomenclature, 2010. Bone Marrow Transplant (2010) 0.96
DNA recommendations 1997 of the International Society for Forensic Genetics. Vox Sang (1998) 0.95
Lymphocyte transformation to denatured type I collagen and B lymphocyte alloantigens in rheumatoid arthritis. Arthritis Rheum (1980) 0.94
Nomenclature for factors of the HLA system, 1991. Hum Immunol (1992) 0.93
HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum (1980) 0.92
Ia-Type alloantigens and humoral autoimmune responsiveness in insulin-dependent diabetes mellitus. Metabolism (1979) 0.92
HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. J Clin Endocrinol Metab (1983) 0.91
Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest (2006) 0.91
Nomenclature for factors of the HLA System, 1998. Hum Immunol (1999) 0.91
Genotyping for red blood cell polymorphisms. Vox Sang (2009) 0.90
Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT). Cytometry (1996) 0.89
Nomenclature for factors of the HLA system, 2000. Hum Immunol (2001) 0.88
Terminal deletion of (1)(q42) and its phenotypical manifestations. Hum Genet (1978) 0.88
Detection of bacterial contamination of platelet concentrates. Vox Sang (2007) 0.88
HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis. Urol Res (1989) 0.88
Alpha-1-antitrypsin phenotypes in acute anterior uveitis. Ophthalmic Res (1982) 0.88
The importance of HLA genes to susceptibility in the development of juvenile diabetes mellitus. A study of 93 patients and 68 first degree blood relations. Diabete Metab (1977) 0.87
Plasmodium falciparum malaria and the immunogenetics of ABO, HLA, and CD36 (platelet glycoprotein IV). Vox Sang (2011) 0.87
Genetic and population structure of four Sardinian villages. Ann Hum Genet (1985) 0.87
[Islet-cell antibodies in juvenile diabetes mellitus (author's transl)]. Dtsch Med Wochenschr (1977) 0.86
Haemolytic transfusion reactions due to HLA antibodies. A prospective study combining red-cell serology with investigations of chromium-51-labelled red-cell kinetics. Lancet (1987) 0.86
Nomenclature for factors of the HLA System, 1996. Hum Immunol (1997) 0.86
Occult hepatitis B infection in blood donors. Vox Sang (2008) 0.86
Biobanks of blood from donors and recipients of blood products. Vox Sang (2008) 0.86
Corneal grafting--strategy for optimal results. Tissue Antigens (1989) 0.85
Nomenclature for factors of the HLA system, 1996. Eur J Immunogenet (1997) 0.85
Immunoglobulin G-insulin antibodies and immune region-associated alloantigens in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1979) 0.85
Molecular genetics of the HLA complex. Wien Klin Wochenschr (2001) 0.85
Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: correlation with clinical and immunological parameters. Rheumatol Int (1981) 0.85
HLA-DR antigens and disease patterns of rheumatoid arthritis. Rheumatol Int (1983) 0.84
Letter: Is HLA-B7 a marker associated with a protective gene in juvenile-onset diabetes mellitus? N Engl J Med (1976) 0.84
Nomenclature for factors of the HLA system, 1994. Hum Immunol (1994) 0.84
Nomenclature for factors of the HLA system, 1989. Hum Immunol (1990) 0.84
Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders. Br J Haematol (1996) 0.83
B-lymphocyte alloantigens and insulin-dependent diabetes mellitus. Lancet (1977) 0.83
HLA-A, B, C gene and haplotype frequencies in Vienna. An analysis of family data. Hum Genet (1977) 0.83
Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology (1997) 0.83
Algorithm for the computation of plausibilities of paternity in the HLA system. Z Immunitatsforsch Immunobiol (1976) 0.83
Genetic analysis and biological properties of products of the third SD (AJ) locus of the HL-A region. Transplant Proc (1973) 0.83
Nomenclature for factors of the HLA system, 1991. Immunobiology (1993) 0.82
[Analysis of the linkage between the HL-A loci and the genes of other markers (author's transl)]. Humangenetik (1974) 0.82
HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onset. Arch Dermatol Res (1978) 0.82
HLA-B8 in caucasian patients with systemic lupus erythematosus. Scand J Rheumatol (1978) 0.82
Human platelet antigen gene frequencies in the Austrian population. Haemostasis (1995) 0.82
Letter: Genetic factors on insulin antibodies in juvenile-onset diabetes. N Engl J Med (1976) 0.82
Nomenclature for factors of the HLA system, 2004. Int J Immunogenet (2005) 0.81
Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany. Ann Hematol (1996) 0.81
Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet (1985) 0.81
Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution. Transfusion (2002) 0.81
Graft versus host disease after orthotopic liver transplantation documented by analysis of short tandem repeat polymorphisms. Digestion (2007) 0.81
[Histocompatibility antigens and open-angle glaucoma (author's transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1977) 0.81
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country. Bone Marrow Transplant (2011) 0.81
HL-A8, W15 and T3 in juvenile onset diabetes mellitus. Horm Metab Res (1975) 0.81
RB, a determinant defined by lymphocytotoxicity being associated with ABO blood groups and ABH secretor status. Further evidence that RB is not produced by lymphocytes. J Immunogenet (1976) 0.81
Nomenclature for HLA microsatellites. Tissue Antigens (2007) 0.81
HLA typing from human donor eyes. Graefes Arch Clin Exp Ophthalmol (1989) 0.81
Human chimerism. Rev Fr Transfus Immunohematol (1981) 0.80